Validation of Quality Indicators for Evaluating Geriatric Pharmacotherapy Services in Primary Care: a Mixed Methods Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2023 Mar 23

PMID 36958785

Authors

Noriko Sato

Kenji Fujita

Hiroshi Okada

Kazuki Kushida

Timothy F Chen

Affiliations

Soon will be listed here.

Abstract

Objective: To assess measurement properties of 121 face and content validated quality indicators (QIs) for medication safety in geriatric pharmacotherapy in primary care.

Design: A mixed methods study: a 6-month observational study in primary care (July-December 2020) and in-depth semistructured online interviews with participants (February-March 2021).

Setting: Sixty community pharmacies in Japan.

Participants: Patients aged 75 years and older who were regularly taking six or more prescription medicines for ˃4 weeks were eligible. The observational study included 457 patients. The interviews were undertaken with 26 community pharmacists, including pharmacy managers and owners.

Primary And Secondary Outcome Measures: Five measurement properties of QIs (applicability, improvement potential, acceptability, implementation issues and sensitivity to change) were evaluated. A web application was developed for data reporting and data visualisation.

Results: This study showed that 53 QIs met the measurement properties of applicability, improvement potential, acceptability and implementation issues. Of 53 QIs, 17 also had a high sensitivity to change. Interviews identified eight themes (indicator characteristics, web application, policy, patient, time, competence, pharmacy administration and collaboration) in relation to the consequence of implementation of QIs.

Conclusions: A set of 121 QIs for geriatric pharmacotherapy was field tested for their five measurement properties. This QI set can be used to identify patients who may benefit from clinician reviews of their medicines. These QIs may be applied at different levels within the healthcare system: patient, pharmacy, regional and national levels. Further mechanisms to automatically collect and report data should be established to facilitate sustainable quality improvement initiatives.

Citing Articles

Pharmaceutical Care Network Europe definition of quality indicators for pharmaceutical care: a systematic literature review and international consensus development.

Fujita K, Halvorsen K, Sato N, Jazbar J, Modamio P, Waltering I Int J Clin Pharm. 2023; 46(1):70-79.

PMID: 37646963 PMC: 10830737. DOI: 10.1007/s11096-023-01631-8.

References

Hommel I, van Gurp P, Tack C, Wollersheim H, Hulscher M . Perioperative diabetes care: development and validation of quality indicators throughout the entire hospital care pathway. BMJ Qual Saf. 2015; 25(7):525-34. DOI: 10.1136/bmjqs-2015-004112. View

Wu H, Kouladjian Odonnell L, Fujita K, Masnoon N, Hilmer S . Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions. Int J Gen Med. 2021; 14:3793-3807. PMC: 8317936. DOI: 10.2147/IJGM.S253177. View

Arcenillas P, Boix-Palop L, Gomez L, Xercavins M, March P, Martinez L . Assessment of Quality Indicators for Appropriate Antibiotic Use. Antimicrob Agents Chemother. 2018; 62(12). PMC: 6256780. DOI: 10.1128/AAC.00875-18. View

Page A, Falster M, Litchfield M, Pearson S, Etherton-Beer C . Polypharmacy among older Australians, 2006-2017: a population-based study. Med J Aust. 2019; 211(2):71-75. DOI: 10.5694/mja2.50244. View

Todd A, Copeland A, Husband A, Kasim A, Bambra C . Access all areas? An area-level analysis of accessibility to general practice and community pharmacy services in England by urbanity and social deprivation. BMJ Open. 2015; 5(5):e007328. PMC: 4431167. DOI: 10.1136/bmjopen-2014-007328. View

Sato N, Fujita K, Kushida K, Chen T . Development and consensus testing of quality indicators for geriatric pharmacotherapy in primary care using a modified Delphi study. Int J Clin Pharm. 2022; 44(2):517-538. PMC: 9007756. DOI: 10.1007/s11096-022-01375-x. View

Fujita K, Kushida K, Moles R, Chen T . Home healthcare professionals' perspectives on quality dimensions for home pharmaceutical care in Japan. Geriatr Gerontol Int. 2018; 19(1):35-43. DOI: 10.1111/ggi.13562. View

Miller D, Litwin M, Sanda M, Montie J, Dunn R, Resh J . Use of quality indicators to evaluate the care of patients with localized prostate carcinoma. Cancer. 2003; 97(6):1428-35. DOI: 10.1002/cncr.11216. View

Hermens R, Ouwens M, Vonk-Okhuijsen S, van der Wel Y, Tjan-Heijnen V, van den Broek L . Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline. Lung Cancer. 2006; 54(1):117-24. DOI: 10.1016/j.lungcan.2006.07.001. View

10.

Tong A, Sainsbury P, Craig J . Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007; 19(6):349-57. DOI: 10.1093/intqhc/mzm042. View

11.

Wenger N, Roth C, Martin D, Nickels L, Beckman R, Kamberg C . Quality of care provided in a special needs plan using a nurse care manager model. J Am Geriatr Soc. 2011; 59(10):1810-22. DOI: 10.1111/j.1532-5415.2011.03599.x. View

12.

Komagamine J, Kobayashi M . Prevalence of hospitalisation caused by adverse drug reactions at an internal medicine ward of a single centre in Japan: a cross-sectional study. BMJ Open. 2019; 9(8):e030515. PMC: 6687054. DOI: 10.1136/bmjopen-2019-030515. View

13.

Emond Y, Stienen J, Wollersheim H, Bloo G, Damen J, Westert G . Development and measurement of perioperative patient safety indicators. Br J Anaesth. 2015; 114(6):963-72. DOI: 10.1093/bja/aeu561. View

14.

Walsh K, ORiordan D, Kearney P, Timmons S, Byrne S . Improving the appropriateness of prescribing in older patients: a systematic review and meta-analysis of pharmacists' interventions in secondary care. Age Ageing. 2016; 45(2):201-9. DOI: 10.1093/ageing/afv190. View

15.

Wenger N, Roth C, Shekelle P . Introduction to the assessing care of vulnerable elders-3 quality indicator measurement set. J Am Geriatr Soc. 2007; 55 Suppl 2:S247-52. DOI: 10.1111/j.1532-5415.2007.01328.x. View

16.

Joling K, van Eenoo L, Vetrano D, Smaardijk V, Declercq A, Onder G . Quality indicators for community care for older people: A systematic review. PLoS One. 2018; 13(1):e0190298. PMC: 5760020. DOI: 10.1371/journal.pone.0190298. View

17.

Kondo Y, Ishitsuka Y, Shigemori E, Irikura M, Kadowaki D, Hirata S . Correction to: Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey. BMC Health Serv Res. 2021; 21(1):617. PMC: 8240377. DOI: 10.1186/s12913-021-06631-w. View

18.

Vandenbroucke J, von Elm E, Altman D, Gotzsche P, Mulrow C, Pocock S . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007; 18(6):805-35. DOI: 10.1097/EDE.0b013e3181577511. View

19.

Campbell S, Braspenning J, Hutchinson A, Marshall M . Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care. 2002; 11(4):358-64. PMC: 1758017. DOI: 10.1136/qhc.11.4.358. View

20.

OMahony D, OSullivan D, Byrne S, OConnor M, Ryan C, Gallagher P . STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014; 44(2):213-8. PMC: 4339726. DOI: 10.1093/ageing/afu145. View